MAPT and Alzheimer disease: Many studies have examined sex differences in the burden of AD pathology and generally find that females typically show a greater burden of pathological tau than males, particularly among amyloid positive individuals who are either cognitively normal or have mild cognitive impairment (MCI) [2–6].